首页> 外文期刊>BMC Neurology >Mechanisms, predictors and clinical impact of early neurological deterioration: the protocol of the Trondheim early neurological deterioration study
【24h】

Mechanisms, predictors and clinical impact of early neurological deterioration: the protocol of the Trondheim early neurological deterioration study

机译:早期神经劣化的机制,预测因子和临床影响:Trondheim早期神经劣化研究的方案

获取原文
           

摘要

Background 10-40% of patients with acute ischemic stroke (AIS) suffer an early neurological deterioration (END), which may influence their long term prognosis. Multiple definitions of END exist, even in recently published papers. In the search for causes, various biochemical, clinical, and imaging markers have been found to be associated to END after AIS in some but not in other studies. The primary aim of this study is to assess the contribution of END to functional level at 3 months post stroke measured by modified Rankin Scale (mRS). Secondary aims are to identify factors and mechanisms associated with END and to define the prevalence, degree and timing of END in relation to stroke onset, and to compare Scandinavian Stroke Scale (SSS) and National Institute of Health Stroke Scale (NIHSS) based END-definitions. We hypothesized that END detected by changes in NIHSS and SSS (according to previously published criteria) at a threshold of 2 points indicate worsened prognosis, and that SSS is not inferior to NIHSS in predicting such a change. We further hypothesized that clinical deterioration has several causes, including impaired physiological homeostasis, vascular pathology, local effects and reactions secondary to the ischemic lesion, along with biochemical disturbances. Methods Single-centre prospective observational study. Participants: Previously at home-dwelling patients admitted to our stroke unit within 24 hours after ictus of AIS are included into the study, and followed for 3 months. They are managed according to current procedures and national guidelines. A total of 368 patients are included by the end of the enrolment period (December 31st 2013), and the material will be opened for analysis by June 30th 2014. Frequent neurological assessments, continuous monitoring, and repeated imaging and blood samples are performed in all patients in order to test the hypotheses. Discussion Strengths and weaknesses of our approach, along with reasons for the methods chosen in this study are discussed.
机译:背景技术10-40%的急性缺血性脑卒中患者(AIS)患有早期神经劣化(终端),其可能影响其长期预后。即使在最近发表的论文中,也存在多种结束的定义。在寻找原因,已经发现各种生化,临床和成像标记物与某些但不在其他研究中的AIS后结束。本研究的主要目的是评估通过修改的Rankin规模(MRS)测量的卒中后3个月结束对功能水平的贡献。次要目标是识别与结束相关的因素和机制,并确定与中风发作相关的普遍存在,程度和时机,并比较斯堪的纳维亚中风规模(SSS)和国家健康冲程量表(NIHSS)的结束 - 定义。我们假设通过NIHS和SSS的变化(根据先前公布的标准)在2点的阈值下检测到的结束表明预后恶化,并且SSS不逊于预测这种变化。我们进一步假设临床劣化具有几种原因,包括生理稳态,血管病理学,局部疗效受损,缺血性病变以及生物化学干扰。方法单中心前瞻性观察研究。参与者:以前在家庭住宅的患者入院患者在AIS的ICTU后24小时内纳入研究,并随访3个月。它们根据当前程序和国家指南进行管理。入学期结束时共有368名患者(12月31日 St 2013),并将在6月30日 th 2014年进行分析。频繁在所有患者中进行神经系统评估,连续监测和反复成像和血液样本,以便测试假设。讨论了我们方法的讨论优势和弱点以及本研究中选择的方法的原因。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号